Who Supplies Pazopanib? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Pazopanib exports, with 109+ registered manufacturers shipping to buyers across 57+ countries — yet a handful of companies dominate the shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest share at 64.4% (export value: $5.4M). Close behind, SP ACCURE LABS PRIVATE LIMITED (12.0%, $1.0M). GNH INDIA PHARMACEUTICALS LIMITED (3.4%, $282.3K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Pazopanib? Top Manufacturers & Their Buyers
Flow of Pazopanib from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Pazopanib Supplier Network — Key Market Intelligence
The Pazopanib export market from India is led by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone commands a 64.4% share, shipping $5.4M worth of product across 9 shipments. The second-largest exporter, SP ACCURE LABS PRIVATE LIMITED, contributes $1.0M (12.0%) to the overall market. Combined, the top two suppliers alone account for 76.4% of all Pazopanib exports, indicating a relatively concentrated supply base.
Across all 109 tracked manufacturers, the total Pazopanib export value stands at $8.3M from 498 shipments. The market average shipment value is $16.8K. The single largest buyer relationship in terms of trade value is SUN PHARMACEUTICAL INDUSTRIES,INC., receiving $3.1M worth of product.
The combined buyer network spans 4 named purchasing companies, including SUN PHARMACEUTICAL INDUSTRIES,INC., M/S.NOVUGEN ONCOLOGY SDN.BHD, TISHAS ADDITIONAL LIABILITY COMPANY, 142 DAVIT AGHMASHENE. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Pazopanib exporter from India, with a market share of 64.4% and a total export value of $5.4M across 9 shipments. Their average shipment value of $597.2K is above the market average of $16.8K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 2 named buyers in our database. SUN PHARMACEUTICAL INDUSTRIES,INC. is the dominant customer, accounting for 57.3% of this supplier's tracked business. Top customers include:
• SUN PHARMACEUTICAL INDUSTRIES,INC. — $3.1M across 5 shipments (57.3% of this supplier's total exports)
• SUN PHARMACEUTICAL INDUSTRIES,INC. — $2.3M across 4 shipments (42.7% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $597.2K is 3462% above the market average of $16.8K, consistent with large-order contracts or value-added formulations.
2SP ACCURE LABS PRIVATE LIMITED
SP ACCURE LABS PRIVATE LIMITED is the second-largest Pazopanib exporter from India, with a market share of 12.0% and a total export value of $1.0M across 6 shipments. Their average shipment value of $167.1K is above the market average of $16.8K, suggesting premium or bulk contract pricing.
SP ACCURE LABS PRIVATE LIMITED serves 1 named buyer in our database. SUN PHARMACEUTICAL INDUSTRIES,INC. is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• SUN PHARMACEUTICAL INDUSTRIES,INC. — $1.0M across 6 shipments (100.0% of this supplier's total exports)
Key Insight: SP ACCURE LABS PRIVATE LIMITED's per-shipment value of $167.1K is 897% above the market average of $16.8K, consistent with large-order contracts or value-added formulations.
3GNH INDIA PHARMACEUTICALS LIMITED
GNH INDIA PHARMACEUTICALS LIMITED is the third-largest Pazopanib exporter from India, with a market share of 3.4% and a total export value of $282.3K across 6 shipments. Their average shipment value of $47.1K is above the market average of $16.8K, suggesting premium or bulk contract pricing.
GNH INDIA PHARMACEUTICALS LIMITED serves 1 named buyer in our database. M/S.NOVUGEN ONCOLOGY SDN.BHD is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• M/S.NOVUGEN ONCOLOGY SDN.BHD — $282.3K across 6 shipments (100.0% of this supplier's total exports)
Key Insight: GNH INDIA PHARMACEUTICALS LIMITED's per-shipment value of $47.1K is 181% above the market average of $16.8K, consistent with large-order contracts or value-added formulations.
4TEYRO LABS PRIVATE LIMITED
TEYRO LABS PRIVATE LIMITED is the fourth-largest Pazopanib exporter from India, with a market share of 0.9% and a total export value of $74.0K across 6 shipments. Their average shipment value of $12.3K is below the market average of $16.8K, reflecting a high-volume, competitive pricing strategy.
TEYRO LABS PRIVATE LIMITED serves 1 named buyer in our database. TISHAS ADDITIONAL LIABILITY COMPANY is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• TISHAS ADDITIONAL LIABILITY COMPANY — $74.0K across 6 shipments (100.0% of this supplier's total exports)
Key Insight: TEYRO LABS PRIVATE LIMITED operates with high shipment frequency (6 shipments) at a per-shipment value of $12.3K, indicating a broad distribution network with many smaller, regular orders.
5MYGENIC HEALTHCARE PRIVATE LIMITED
MYGENIC HEALTHCARE PRIVATE LIMITED is the fifth-largest Pazopanib exporter from India, with a market share of 0.9% and a total export value of $73.7K across 21 shipments. Their average shipment value of $3.5K is below the market average of $16.8K, reflecting a high-volume, competitive pricing strategy.
MYGENIC HEALTHCARE PRIVATE LIMITED serves 1 named buyer in our database. 142 DAVIT AGHMASHENE is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• 142 DAVIT AGHMASHENE — $73.7K across 21 shipments (100.0% of this supplier's total exports)
Key Insight: MYGENIC HEALTHCARE PRIVATE LIMITED operates with high shipment frequency (21 shipments) at a per-shipment value of $3.5K, indicating a broad distribution network with many smaller, regular orders.
6BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED is the fifth-largest Pazopanib exporter from India, with a market share of 0.0% and a total export value of $0 across 3 shipments. Their average shipment value of $0 is below the market average of $16.8K, reflecting a high-volume, competitive pricing strategy.
Key Insight: BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED operates with high shipment frequency (3 shipments) at a per-shipment value of $0, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Pazopanib Flows
Once Pazopanib leaves the manufacturing plants of companies like SUN PHARMACEUTICAL INDUSTRIES LIMITED and SP ACCURE LABS PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $8.3M. United States absorbs the largest share at 84.4% ($7.0M), followed by Georgia (2.6%) and Taiwan (2.3%).
In United States — the top destination — named importers include SUN PHARMACEUTICAL INDUSTRIES INC, SUN PHARMACEUTICAL INDUSTRIES,INC., M/S.NOVUGEN ONCOLOGY SDN.BHD. In Georgia, key buyers are 142 DAVIT, MERMISI LLC.
This geographic spread reflects Pazopanib's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Pazopanib Go? Top Importing Countries & Their Buyers
Trade flow of Pazopanib exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Pazopanib imports from India, with a total trade value of $7.0M across 15 shipments — representing a 84.4% share of all Pazopanib exports. The average shipment value of $470.0K is above the global average of $16.8K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Pazopanib importers in United States: SUN PHARMACEUTICAL INDUSTRIES INC is the largest buyer, accounting for 46.8% ($3.3M) of this market's total imports.
• SUN PHARMACEUTICAL INDUSTRIES INC — $3.3M (46.8% of United States's total)
• SUN PHARMACEUTICAL INDUSTRIES,INC. — $3.3M (46.3% of United States's total)
• M/S.NOVUGEN ONCOLOGY SDN.BHD — $282.3K (4.0% of United States's total)
Key Insight: United States's per-shipment average of $470.0K (2703% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Pazopanib imports from India.
2Georgia
Georgia ranks as the second-largest destination for Pazopanib imports from India, with a total trade value of $212.9K across 7 shipments — representing a 2.6% share of all Pazopanib exports. The average shipment value of $30.4K is above the global average of $16.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Pazopanib importers in Georgia: 142 DAVIT is the largest buyer, accounting for 19.8% ($42.2K) of this market's total imports.
• 142 DAVIT — $42.2K (19.8% of Georgia's total)
• MERMISI LLC — $27.1K (12.8% of Georgia's total)
Key Insight: Georgia's per-shipment average of $30.4K (81% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Georgia is a key market for Pazopanib imports from India.
3Taiwan
Taiwan ranks as the third-largest destination for Pazopanib imports from India, with a total trade value of $192.9K across 2 shipments — representing a 2.3% share of all Pazopanib exports. The average shipment value of $96.5K is above the global average of $16.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Pazopanib importers in Taiwan: LOTUS PHARMACEUTICAL CO.LTD., is the largest buyer, accounting for 100.0% ($192.9K) of this market's total imports.
• LOTUS PHARMACEUTICAL CO.LTD., — $192.9K (100.0% of Taiwan's total)
Key Insight: Taiwan's per-shipment average of $96.5K (475% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Taiwan is a key market for Pazopanib imports from India.
4Sri Lanka
Sri Lanka ranks as the fourth-largest destination for Pazopanib imports from India, with a total trade value of $161.5K across 4 shipments — representing a 1.9% share of all Pazopanib exports. The average shipment value of $40.4K is above the global average of $16.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Pazopanib importers in Sri Lanka: STATE PHARMACEUTICALS CORPORATION is the largest buyer, accounting for 96.9% ($156.6K) of this market's total imports.
• STATE PHARMACEUTICALS CORPORATION — $156.6K (96.9% of Sri Lanka's total)
Key Insight: Sri Lanka's per-shipment average of $40.4K (141% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Pazopanib imports from India.
5Belarus
Belarus ranks as the fifth-largest destination for Pazopanib imports from India, with a total trade value of $150.1K across 2 shipments — representing a 1.8% share of all Pazopanib exports. The average shipment value of $75.0K is above the global average of $16.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Pazopanib importers in Belarus: TISHAS ADDITIONAL LIABILITY COMPANY is the largest buyer, accounting for 100.0% ($150.1K) of this market's total imports.
• TISHAS ADDITIONAL LIABILITY COMPANY — $150.1K (100.0% of Belarus's total)
Key Insight: Belarus's per-shipment average of $75.0K (348% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belarus is a key market for Pazopanib imports from India.
People Also Ask — Pazopanib Supplier & Trade Network
Who are the top suppliers of Pazopanib from India?+
Which companies buy Pazopanib from Indian manufacturers?+
Where does Pazopanib exported from India go?+
What is the market share of the top Pazopanib supplier from India?+
What is the average shipment value for Pazopanib exports from India?+
Is Pazopanib manufactured in India and exported globally?+
Which country imports the most Pazopanib from India?+
Who are the buyers of Pazopanib in Georgia?+
How concentrated is the Pazopanib supplier market in India?+
How do I find verified buyers for Pazopanib in specific countries?+
Pazopanib Trade Network — Key Takeaways
- 1SUN PHARMACEUTICAL INDUSTRIES LIMITED is India's dominant Pazopanib exporter with a 64.4% market share and $5.4M in total exports — making it the single most important sourcing entity in this market.
- 2The top 109 suppliers collectively account for 81.5% of all tracked Pazopanib exports, with a combined trade value of $8.3M.
- 3United States is the largest destination market, absorbing 84.4% of India's Pazopanib exports ($7.0M). Georgia (2.6%) and Taiwan (2.3%) follow.
- 4With 498 total shipments averaging $16.8K each, the Pazopanib export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES,INC., M/S.NOVUGEN ONCOLOGY SDN.BHD — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 2 customers
6 suppliers → 57 countries
Network value: $8.3M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pazopanib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Pazopanib.
- 2.Flow Mapping: 109 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 498 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 57 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
498 Verified Shipments
109 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists